117 related articles for article (PubMed ID: 38894915)
1. Novel Furopyridine and Furopyrimidine Compounds as PI4K Inhibitors for Treating Malaria and Viral Infection.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):779-780. PubMed ID: 38894915
[TBL] [Abstract][Full Text] [Related]
2. Research progress of phosphatidylinositol 4-kinase and its inhibitors in inflammatory diseases.
Li YP; Mikrani R; Hu YF; Faran Ashraf Baig MM; Abbas M; Akhtar F; Xu M
Eur J Pharmacol; 2021 Sep; 907():174300. PubMed ID: 34217706
[TBL] [Abstract][Full Text] [Related]
3. Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19.
Sabnis RW
ACS Med Chem Lett; 2023 Sep; 14(9):1150-1151. PubMed ID: 37736189
[TBL] [Abstract][Full Text] [Related]
4. Protease Inhibitors for Treating or Preventing Coronavirus Infection.
Sabnis RW
ACS Med Chem Lett; 2023 Nov; 14(11):1489-1490. PubMed ID: 37974953
[TBL] [Abstract][Full Text] [Related]
5. Novel Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Sep; 14(9):1152-1153. PubMed ID: 37736181
[TBL] [Abstract][Full Text] [Related]
6. Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):775-776. PubMed ID: 38894910
[TBL] [Abstract][Full Text] [Related]
7. Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):748-749. PubMed ID: 38894901
[TBL] [Abstract][Full Text] [Related]
8. Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1336-1337. PubMed ID: 37849559
[TBL] [Abstract][Full Text] [Related]
9. Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1334-1335. PubMed ID: 37849539
[TBL] [Abstract][Full Text] [Related]
10. Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Aug; 14(8):1045-1046. PubMed ID: 37583830
[TBL] [Abstract][Full Text] [Related]
11. Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jun; 14(6):707-708. PubMed ID: 37312857
[TBL] [Abstract][Full Text] [Related]
12. Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):555-556. PubMed ID: 37197476
[TBL] [Abstract][Full Text] [Related]
13. Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):777-778. PubMed ID: 38894904
[TBL] [Abstract][Full Text] [Related]
14. Novel Phosphorylpurinone Compounds for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):441-442. PubMed ID: 38628787
[TBL] [Abstract][Full Text] [Related]
15. Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):177-178. PubMed ID: 38352847
[TBL] [Abstract][Full Text] [Related]
16. Novel CD73 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):571-572. PubMed ID: 38746902
[TBL] [Abstract][Full Text] [Related]
17. Novel ACC Inhibitors for Treating Acne.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):445-446. PubMed ID: 38628789
[TBL] [Abstract][Full Text] [Related]
18. Novel PARP1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):161-162. PubMed ID: 38352834
[TBL] [Abstract][Full Text] [Related]
19. Novel PARP7 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1615-1616. PubMed ID: 38116422
[TBL] [Abstract][Full Text] [Related]
20. Novel PARP1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1629-1630. PubMed ID: 38116419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
